Evolution of the Therapeutic Care in Metastatic Breast Cancer From 2008
ConditionMetastatic Breast Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUNICANCER
About this trial
The Epidemiological Strategy and Medical Economic (ESME) Breast cancer Database is a multicenter real life database using a retrospective data collection process across 18 French comprehensive cancer centers (FCCC) spread over 20 sites. This database compiles data from patient's electronic medical records (EMR).
Eligibility criteria
Qualifiers
18 years old patient
Patient receiving chemotherapy, targeted therapy, immunotherapy, radiation therapy and hormonotherapy in a French Comprehensive Cancer Center.
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
UNICANCER
Lead sponsor
Roche Pharma AG
Collaborator
Pierre Fabre Laboratories
Collaborator
Pfizer
Collaborator
AstraZeneca
Collaborator
Merck Sharp & Dohme LLC
Collaborator
Eisai Inc.
Collaborator
Daiichi Sankyo
Collaborator
Eli Lilly and Company
Collaborator
Gilead Sciences
Collaborator
Seagen Inc.
Collaborator
Source ClinicalTrials.gov